Your new post is loading...
The diversified company is collaborating with Texas Medical Center, the largest medical center in the world, to launch a medical device incubator where internal research projects as well as those working with outside entrepreneurs.
Via rob halkes
|
Rescooped by Philippe Marchal from New pharma |
Scoop.it!
Via rob halkes
Like we ascertained in our research for EyeforPharma, (2015, also in 2013) the innovating pharma industry like J&J is seriously advancing in creating services to innovate healthcare beyond the therapy, "beyond the pill" also. The hype around "Patient Centricity" seems to have overflown this promising but difficult development. "beyoind the Pill" strategies go beyond "Patient Centricity," of which the pharma community is not yet able to define it. A strategic discussion might be in place for a company to look at how the business model might be developed according to demands from different regions in the global market and and innovative developments in health care itself. And so, exploring how working "beyond the pill" might be of the best of interests of patients, like they themselves would see this.